118 related articles for article (PubMed ID: 36905257)
1. Value of TCT combined with HPV and CA125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
3. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
4. ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients.
Husaiyin S; Jiao Z; Yimamu K; Maisaidi R; Han L; Niyazi M
PLoS One; 2021; 16(12):e0260915. PubMed ID: 34855928
[TBL] [Abstract][Full Text] [Related]
5. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
6. The clinical research of Thinprep Cytology Test (TCT) combined with HPV-DNA detection in screening cervical cancer.
Liu Y; Zhang L; Zhao G; Che L; Zhang H; Fang J
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):92-95. PubMed ID: 28364788
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of combined detection of thinprep cytology test and high risk human papillomavirus hybrid capture 2 assay in the screening and recurrence predication of cervical intraepithelial neoplasia].
Xu XY; Zhao W; Li GJ; Jin XY; Li YZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2503-5. PubMed ID: 23158720
[TBL] [Abstract][Full Text] [Related]
8. Triage human papillomavirus testing for cytology-based cervical screening in women of different ages in primary hospitals: A retrospective clinical study.
Zhang YY; Xu XQ; Zhang D; Wu J; Zhang HX
Medicine (Baltimore); 2020 Sep; 99(38):e22320. PubMed ID: 32957398
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
Fan Y; Shen Z
Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
11. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.
Liang H; Fu M; Zhou J; Song L
Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
[TBL] [Abstract][Full Text] [Related]
13. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
14. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
15. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
16. [The value of p16(INK4a) cytology for early diagnosis of cervical cancer].
Duan LF; Du H; Xiao AM; Wang C; Yan PS; Huang X; Wu RF
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):812-815. PubMed ID: 32746548
[No Abstract] [Full Text] [Related]
17. Study on the Significance of Folate Receptor-Mediated Staining Solution (FRD) Staining in Screening High Grade Cervical Lesions.
Xiao S; Xie H; Zhu X; Li X; Yi S; Deng X; Xue M
Med Sci Monit; 2019 Apr; 25():2792-2801. PubMed ID: 30990212
[TBL] [Abstract][Full Text] [Related]
18. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
20. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
